PNPLA3 and metabolic dysfunction-associated steatotic liver disease: A recent study demonstrated that specific genetic variants, such as patatin-like phospholipase domain-containing 3 (PNPLA3), or biomarkers, can possibly be used to predict the progression of NAFLD [42,43,44].